Abiopharma

🔍 WEINRAUCH STEVE (Executive)

Company: TRUPANION, INC. (TRUP)

Report Date: 2026-06-05

Detailed Transactions and Holdings:

• Acquired 8,500 shares of Common Stock at $15.46 per share (Direct)
  Date: 2026-06-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 84,736.00 | transaction_form_type: 4
• Sold 6,674 shares of Common Stock at $22.0 per share (Direct)
  Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 78,062.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 8,500 shares of Stock Option (right to buy) at $15.46 per share (Derivative)
  Date: 2026-06-05 | Code: M | Expires: 2026-07-22 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.95 to $22.04 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
• F2: On July 22, 2016, the reporting person was granted 8,500 stock options. The stock options vested as to 25% of the total shares on July 22, 2017, and then 1/48th of the total stock options vested monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.